期刊文献+

EGFR特异性单链抗体与靶细胞结合的特异性 被引量:2

The Specificity of EGFR scFv Binding with Target Cells
下载PDF
导出
摘要 目的:检测EGFR特异性单链抗体F4-scFv与EGFR阳性及阴性细胞结合特性。方法:提取细菌周质腔蛋白经N i-NTA柱纯化F4-scFv;采用流式细胞术及W estern b lot检测F4-scFv与EGFR阳性及阴性细胞结合的特异性。结果:N i2+柱纯化的F4-scFv经SDS-PAGE可见分子量为36 kDa单一条带,F4-scFv可与EGFR阳性细胞CHO-EGFR-GFP1、A431及MDA-MB-231特异性结合,而不与EGFR阴性细胞CHO-K1及SKOV3结合。结论:F4-scFv可与天然表达EGFR的细胞特异性结合,为其靶向抗肿瘤研究奠定了基础。 Objective To study the binding properties of an EGFR scFv (F4 - scFv) to EGFR positive and negative cell lines. Methods F4 - scFv was purified from periplasmic fraction of bacteria by IMAC using a Ni - NTA agarose column ; The binding properties of F4 - scFv to EGFR positive and negative cells were analyzed by FCM and Western blot. Results The purified F4 - scFv was migrated as a single band in a SDS - PAGE analysis with molecular size of about 36kDa; F4 - scFv bound EGFR positive cell line CHO - EGFR - GFP1, A431, MDA - MB -231, but didnt bind EGFR negative cell line CHO - K1 and SKOV3. Conclusion F4 - scFv binds specifically to EGFR positive cell lines, this work provides a basis for further research of anti - tumor drugs using this scFv as target molecule.
出处 《郧阳医学院学报》 2006年第4期202-204,F0002,共4页 Journal of Yunyang Medical College
基金 国家重点研究发展规划基金(No:2002CB513109)
关键词 表皮生长因子受体 单链抗体 细胞结合特异性 EGFR scFv Cell binding specificity
  • 相关文献

参考文献6

  • 1Vyas SP,Singh A,Sihorkar V.Ligand-receptor-mediated drug delivery:an emerging paradigm in cellular drug targeting[J].Crit Rev Ther Drug Carrier Syst,2001,18(1):1-76.
  • 2赵晓蓉,曹利民,彭吉林,王敏,赵晓平,吴砂,李文涵,叶庆,沈关心.稳定表达EGFR-GFP融合蛋白细胞系的建立[J].郧阳医学院学报,2006,25(3):129-132. 被引量:4
  • 3De Greeff A,Van Alphen L,Smith HE.Selection of recombinant antibodies specific for pathogenic streptococcus suis by subtractive phage display[J].Infect Immun,2000,68(7):3 949-3 955.
  • 4Normanno N,Bianco C,Strizzi L,et al.The ErbB receptors and their ligands in cancer:an overview[J].Curr Drug Targets,2005,6(3):243-257.
  • 5Mendelsohn J,Baselga J.Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer[J].J Clin Oncol,2003,21(14):2 787-2 799.
  • 6Azemar M,Schmidt M,Arlt F,et al.Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid regression in vivo[J].Int J Cancer,2000,86(2):269-275.

二级参考文献9

  • 1潘国栋,黄永章,郭凌郧,唐俊明,孔霞,YANG Qinglin,王家宁.心肌α肌球蛋白重链启动子驱动的绿色荧光蛋白表达载体的构建及鉴定[J].郧阳医学院学报,2006,25(2):70-73. 被引量:7
  • 2Normanno N,Bianco C,Strizzi L,et al.The ErbB receptors and their ligands in cancer:an overview[J].Curr Drug Targets,2005,6 (3):243-257.
  • 3Brock R,Hamelers IH,Jovin TM.Comparison of fixation protocols for adherent cultured cells applied to a GFP fusion protein of the epidermal growth factor receptor[J].Cytometry,1999,35(4):353-362.
  • 4Perez-Soler R.HER1/EGFR targeting:refining the strategy[J].Oncologist,2004,9(1):58-67.
  • 5Blackledge G,Averbuch S.Gefitinib ('Iressa',ZD1839) and new epidermal growth factor receptor inhibitors[J].Br J Cancer,2004,90(3):566-572.
  • 6Kari C,Chan TO,Rocha de Quadros M,et al.Targeting the epidermal growth factor receptor in cancer:apoptosis takes center stage[J].Cancer Res,2003,63(1):1-5.
  • 7Wahlfors J,Loimas S,Pasanen T,et al.Green fluorescent protein (GFP) fusion constructs in gene therapy research[J].Histochem Cell Biol,2001,115(1):59-65.
  • 8Daly CJ,McGrath JC.Fluorescent ligands,antibodies,and proteins for the study of receptors[J].Pharmacol Ther,2003,100(2):101-118.
  • 9Brock R,Jovin TM.Heterogeneity of signal transduction at the subcellular level:microsphere-based focal EGF receptor activation and stimulation of Shc translocation[J].J Cell Sci,2001,114(13):2 437-2 447.

共引文献3

同被引文献13

  • 1赵晓蓉,曹利民,彭吉林,王敏,赵晓平,吴砂,李文涵,叶庆,沈关心.稳定表达EGFR-GFP融合蛋白细胞系的建立[J].郧阳医学院学报,2006,25(3):129-132. 被引量:4
  • 2VYAS S P,SIHORKAR V.Ligand-receptor-mediated drug delivery:an emerging paradigm in cellular drug targeting[J].Adv Drug Deliv Rev,2001,43:101-164.
  • 3GREEF A D,ALPHEN L V,SMITH H E.Selection of recombinant antibodies specific for pathogenic streptococcus suis by subtractive phage display[J].Infect Immun,2000,68:3949-3955
  • 4SCHIER R,MARKS J D,WOLF E J,et al.In vitro and in vivo characterization of a human anti-c-ErbB2 single chain Fv isolated from a filamentous phage antibody library[J].Immunotechnol,1995,1:73-81.
  • 5LORENO C D,PALMER D B,POCCOLI R,et al.A new human antitumor immunoreagent specific for ErbB2[J].Clin Cancer Res,2002,8:1710-1719.
  • 6GAO C S,MAO S L,RONCA F,et al.De novo identification of tumor-specific internalizating human antibody-receptor pairs by phage-display methods[J].J Immu Meth,2003,274,185-197.
  • 7HEITNER T,MOOR A,GARRISON J L,et al.Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library[J].J Immun Meth,2001,248:17-30.
  • 8夏立新,闫浩,汤慕瑾,朱海,刘志刚.花生过敏原Ara h2与Ara h6的生物信息学比较研究[J].深圳大学学报(理工版),2010,27(2):241-246. 被引量:13
  • 9刘文哲,李金瀚,胡义德,谢剑明,孔令红,钱桂生.顺铂诱导人肺腺癌A549细胞系多重抗药性的形成[J].中国肿瘤临床与康复,1999,6(1):13-16. 被引量:28
  • 10欧阳曙光,贺福初.生物信息学:生物实验数据和计算技术结合的新领域[J].科学通报,1999,44(14):1457-1468. 被引量:38

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部